CRISPR Therapeutics AG

NasdaqGM:CRSP Stock Report

Market Cap: US$4.4b

CRISPR Therapeutics AG Company Information

CRISPR Therapeutics AG's employee growth, exchange listings and data sources


Key Information

  • Name: CRISPR Therapeutics AG
  • Ticker: CRSP
  • Exchange: NasdaqGM
  • Founded: 2013
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$4.406b
  • Shares Outstanding: 85.35m
  • Website: https://www.crisprtx.com

Number of Employees


Location

  • CRISPR Therapeutics AG
  • Baarerstrasse 14
  • Zug
  • Zug
  • 6300
  • Switzerland


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRSPNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDOct 2016
0VRQLSE (London Stock Exchange)YesCommon SharesGBUSDOct 2016
1CGBRSE (Berne Stock Exchange)YesCommon SharesCHCHFOct 2016
CRSP NBMV (Bolsa Mexicana de Valores)YesCommon SharesMXMXNOct 2016
C2RS34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 8 REPR 1 COMBRBRLJan 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/10 01:29
End of Day Share Price 2024/11/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.